Stereotactic radiotherapy or protons for uveal melanoma patients? An artificial intelligence (AI)-based clinical treatment decision-making tool predicting doses to radiotherapy constraints.
Journal:
International journal of radiation oncology, biology, physics
Published Date:
Jul 2, 2025
Abstract
PURPOSE: For ocular melanoma, selecting between stereotactic radiotherapy (SRT) and protons requires a lengthy plan comparison process. The purpose of this brief report is to describe an artificial intelligence (AI) decision-making tool to predict dosimetric and clinical outcomes based on easy-to-access tumor characteristics.
Authors
Keywords
No keywords available for this article.